Sign In
Buy NVAX
$10.20
-0.0100 (-0.0979%)
At Close: Jun 03, 2026
Why Investors Need to Take Advantage of These 2 Medical Stocks Now
09:56am, Tuesday, 24'th Jun 2025
Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.
Novavax (NVAX) Ascends While Market Falls: Some Facts to Note
06:46pm, Friday, 20'th Jun 2025
Novavax (NVAX) concluded the recent trading session at $6.41, signifying a +1.75% move from its prior day's close.
Novavax, Inc. (NVAX) is Attracting Investor Attention: Here is What You Should Know
10:01am, Thursday, 19'th Jun 2025
Recently, Zacks.com users have been paying close attention to Novavax (NVAX). This makes it worthwhile to examine what the stock has in store.
Novavax's COVID-Flu Combo Shot Shows Strong Immune Response
09:16am, Thursday, 12'th Jun 2025
NVAX's COVID-flu combo shot sparks strong immunity in seniors, fueling plans for further late-stage trials.
Novavax, Inc. (NVAX) Presents at Goldman Sachs 46th Annual Global Healthcare Conference Transcript
08:59pm, Wednesday, 11'th Jun 2025
Novavax, Inc. (NASDAQ:NVAX ) Goldman Sachs 46th Annual Global Healthcare Conference June 11, 2025 2:00 PM ET Company Participants James Patrick Kelly - Executive VP, CFO & Treasurer John Charles Jacob
Novavax (NVAX) is a Top-Ranked Momentum Stock: Should You Buy?
10:56am, Wednesday, 11'th Jun 2025
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Novavax's COVID-flu combo and standalone flu shots improve immunity in late-stage study
07:11am, Wednesday, 11'th Jun 2025
Novavax's experimental COVID-19-influenza combination and standalone influenza vaccines showed strong immune responses in some patients tested in a late-stage study, the company said on Wednesday.
Both vaccine candidates induced robust immune responses across all antigens tested No new safety signals were observed and both vaccine candidates were well tolerated consistent with past trials Novav
Vaccine stocks muted as Wall Street takes 'wait and watch' approach after Kennedy's shake-up
09:30am, Tuesday, 10'th Jun 2025
Shares of global vaccine makers were muted on Tuesday as investors and analysts took a "wait and watch" approach after U.S. Health Secretary Robert F. Kennedy Jr. fired all members of an expert vaccin
Why Moderna, Pfizer Stocks Are Shrugging Off RFK Jr.'s Firing of Vaccine Advisors.
08:18am, Tuesday, 10'th Jun 2025
Investors will be waiting for news on how the makeup of a reconstituted ACIP will look like.
Vaccine Stocks Moderna, Pfizer Hit After A Surprise Blow From RFK Jr.
06:07pm, Monday, 09'th Jun 2025
Vaccines stocks slipped late Monday after HHS fired all members of a CDC committee in charge of making vaccine suggestions.
Novavax, Inc. (NVAX) Is a Trending Stock: Facts to Know Before Betting on It
10:06am, Friday, 06'th Jun 2025
Novavax (NVAX) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Novavax to Participate in Upcoming Investor Conferences
08:00am, Thursday, 29'th May 2025
GAITHERSBURG, Md. , May 29, 2025 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX) today announced that it will participate in the following upcoming investor conferences: Jefferies Global Healthcare Conf
Here's Why Novavax (NVAX) is a Strong Momentum Stock
10:55am, Monday, 26'th May 2025
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Novavax, Inc. (NVAX) is Attracting Investor Attention: Here is What You Should Know
10:06am, Monday, 26'th May 2025
Recently, Zacks.com users have been paying close attention to Novavax (NVAX). This makes it worthwhile to examine what the stock has in store.
